THE ASSOCIATION OF NUTRITIONAL STATUS ON FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN CARDIAC AMYLOIDOSIS PATIENTS: AN EXPLORATORY PILOT STUDY

This exploratory pilot study reveals that malnutrition is highly prevalent in cardiac amyloidosis patients, particularly those with the AL subtype, and underscores the limitations of BMI in detecting nutritional deficits while highlighting the critical need for routine screening to improve quality of life and outcomes.

The Gist

Imagine your body is a high-performance car. In Cardiac Amyloidosis, the engine (the heart) is being slowly clogged up with a sticky, waxy substance called "amyloid." This makes the heart stiff and weak, much like trying to drive a car with a clogged fuel filter.

This study is like a mechanic's check-up, but instead of just looking at the engine, the researchers wanted to see how the fuel tank (nutrition) and the driver's stamina (physical ability and happiness) are holding up in these patients.

Here is the story of their findings, broken down simply:

1. The Big Surprise: The "Hidden Hunger"

The researchers looked at 29 patients with this heart condition. They used two different tools to check if the patients were getting enough food and nutrients:

• Tool A (The Scale): They weighed the patients and calculated their BMI (Body Mass Index). This is the standard "car weight" check.
• Tool B (The Interview): They used a detailed questionnaire called the SGA (Subjective Global Assessment). This is like a mechanic asking the driver: "Have you been losing weight without trying? Do you feel sick when you eat? Do you feel weak?"

The Result:

• Tool A (BMI) said: "Everyone looks fine! No one is underweight."
• Tool B (The Interview) said: "Wait a minute! 62% of these patients are actually malnourished."

The Analogy:
Think of a car that looks shiny and heavy on the outside (maybe it has a full tank of gas or even extra cargo), but the engine is starving for high-quality fuel. In these patients, the amyloid disease often causes nausea, vomiting, or trouble swallowing. They might still have a normal weight (or even be overweight), but their bodies are starving for nutrients because they can't keep food down or absorb it properly. Relying only on the scale (BMI) was like judging a car's health only by how heavy it is, ignoring that the engine is sputtering.

2. The Two Types of "Bad Fuel"

There are two main types of this heart disease: AL (caused by bad proteins from the bone marrow) and ATTR (caused by aging or genetics).

• The study found that the "hidden hunger" affected both groups.
• However, the AL patients who were malnourished felt much worse. Their "quality of life" scores (how happy and functional they felt) dropped significantly compared to well-nourished AL patients.
• It's as if the AL patients were driving a car with a clogged filter and a starving driver, making the whole experience miserable.

3. The Engine is Sputtering (Functional Capacity)

The researchers also tested how far the patients could walk in 6 minutes and how strong their hand grips were.

• The Finding: A huge chunk of the malnourished patients had weak muscles and couldn't walk very far.
• The Analogy: If your body is a car, malnutrition is like running on low-grade fuel. The car might still move, but it has no power to climb hills or accelerate. The patients felt weak, tired, and unable to do daily tasks.

4. Why This Matters

The main takeaway is that doctors need to stop just looking at the scale.

• If a doctor sees a patient with this heart disease and says, "Your BMI is normal, you're fine," they might be missing a critical problem.
• The study suggests that doctors need to ask the right questions (like the SGA tool) to find the "hidden hunger."
• The Hope: If we catch this early and fix the nutrition (give the car the right fuel), we might help these patients feel stronger, walk further, and enjoy life more, even if the heart disease itself is hard to cure.

In a Nutshell

This study is a wake-up call. It tells us that in patients with this specific heart disease, being "normal weight" doesn't mean being well-nourished. Many are secretly starving, which makes them feel terrible and weak. By using better tools to find this hidden problem, we can help these patients drive their lives with more energy and less pain.

Technical Summary

1. Problem Statement

Cardiac amyloidosis (CA), caused by the accumulation of misfolded proteins (either Immunoglobulin Light Chain [AL] or Transthyretin [ATTR]), is a systemic disease leading to severe heart failure and extracardiac manifestations. Patients frequently suffer from gastrointestinal symptoms (nausea, vomiting, dysphagia, malabsorption) and anorexia, which predispose them to malnutrition.

Despite the high prevalence of malnutrition in this population, it remains underdiagnosed. Current clinical practice often relies on Body Mass Index (BMI) as a primary screening tool. However, BMI is a poor indicator in CA patients because fluid retention, edema, and the specific nature of amyloid infiltration can mask muscle wasting and weight loss. There is a critical lack of data regarding the specific prevalence of malnutrition in CA, the efficacy of different screening tools (SGA vs. BMI), and the impact of nutritional status on functional capacity and quality of life (QoL) in these patients.

2. Methodology

Study Design:

• Type: Cross-sectional, single-center, observational pilot study.
• Setting: University of Montreal Health Centre (CHUM), Canada.
• Timeline: Data collected between January 2020 and September 2021 (Note: The text mentions March 2025 in the methods section, likely a typo in the preprint, but the abstract specifies 2020–2021).
• Participants: 29 patients with confirmed CA (14 AL, 15 ATTR).
  • Inclusion: Diagnosed CA per Canadian guidelines, age ≥18.
  • Exclusion: Conditions preventing consent or evaluation.

Assessment Tools:

• Nutritional Status:
  • Subjective Global Assessment (SGA): The primary tool. Patients were classified as Well-nourished (SGA-A) or Malnourished (SGA-B/C).
  • Anthropometry: BMI (using WHO and age-adapted cut-offs for elderly), Mid-Arm Muscle Circumference (MAMC), and Triceps Skinfold Thickness.
  • Muscle Depletion: Defined as MAMC below the 10th percentile of reference populations.
• Functional Capacity:
  • Handgrip Strength: Measured via dynamometer; weakness defined as <32.2 kgf.
  • 6-Minute Walk Test (6MWT): Submaximal functional capacity.
  • ECOG Performance Status: General functional scale.
• Quality of Life (QoL):
  • SF-36: General health-related QoL (Physical and Mental Component Summaries).
  • KCCQ: Disease-specific QoL for cardiomyopathy.
• Statistical Analysis: Fisher's exact test for categorical data and T-tests for continuous variables. Significance set at p < 0.05.

3. Key Contributions

• Validation of SGA over BMI: The study provides empirical evidence that BMI is an inadequate screening tool for malnutrition in cardiac amyloidosis, as it failed to identify any cases of underweight in the cohort despite high malnutrition rates.
• Subtype Differentiation: It highlights that while malnutrition is prevalent across the board, its impact on Quality of Life is significantly more pronounced in the AL subtype compared to ATTR.
• Clinical Correlation: It establishes a link between nutritional status (specifically in AL patients) and functional decline (handgrip weakness, ECOG scores) and reduced QoL scores.

4. Key Results

Prevalence of Malnutrition:

• SGA Findings: 62% (n=18) of the total cohort was classified as malnourished (17 mild/moderate, 1 severe).
• BMI Findings: 0% of patients were classified as underweight by standard WHO criteria. Even using age-adapted criteria (<22 kg/m²), only 14% were underweight.
• Discrepancy: There was a significant lack of agreement (Kappa = 0.178) between SGA and BMI. Notably, 17% of malnourished patients (by SGA) were classified as overweight or obese by BMI.

Clinical Characteristics:

• Demographics: Mean age 74.3 years; 79% male. 48% AL, 52% ATTR.
• Symptoms: Malnourished patients reported significantly higher rates of inadequate dietary intake (50% vs 0%), early satiety (50% vs 9.1%), and unintentional weight loss (77.8% vs 18.2%).
• Organ Involvement: No significant difference in the number of affected organs between well-nourished and malnourished groups.

Functional Capacity & QoL:

• General: 62% of the total cohort had handgrip weakness. 62% of malnourished patients had handgrip weakness.
• AL Subtype Specifics: Malnourished AL patients showed statistically significant lower scores compared to well-nourished AL patients in:
  • SF-36 Physical Functioning (p < 0.001)
  • SF-36 Vitality (p = 0.012)
  • SF-36 Physical Component Summary (p = 0.029)
  • KCCQ Physical Limitations (p = 0.007)
• ATTR Subtype Specifics: No statistically significant differences in QoL or functional capacity were found between well-nourished and malnourished ATTR patients, likely due to smaller sample size and different disease trajectory.

5. Significance and Conclusion

• Screening Imperative: The study concludes that relying on BMI alone leads to the underdiagnosis of malnutrition in cardiac amyloidosis. Routine screening using comprehensive tools like the Subjective Global Assessment (SGA) is essential.
• Targeted Intervention: Malnutrition is a modifiable risk factor that correlates with poor functional status and reduced quality of life, particularly in AL amyloidosis. Early identification allows for tailored nutritional interventions.
• Future Directions: The authors call for larger, multi-center studies to validate these findings and to determine if nutritional support improves long-term survival and clinical outcomes in this high-risk population.

Limitations:
The study is limited by its small sample size (n=29), single-center design, and cross-sectional nature, which prevents causal inference. Additionally, the use of cut-offs derived from other populations (e.g., heart failure) for functional assessments may limit specificity.